IV vs Targeted Stem Cell Injection: Which Delivery Method Is Best?

Compare intravenous systemic delivery and targeted local stem cell injections. Which administration route works best for different conditions and how protocols are tailored to each patient.

Intravenous (IV) Delivery: How It Works and When It Is Used

IV infusion delivers MSCs into a peripheral vein, from which they travel through the bloodstream. MSCs do not circulate freely for long — within hours, the majority are trapped in the pulmonary capillary bed (the "pulmonary first pass" effect), releasing their anti-inflammatory and immunomodulatory secretome into systemic circulation before being gradually redistributed. Despite not reaching target organs in large numbers, the systemic release of MSC paracrine factors produces meaningful whole-body immunomodulatory effects. IV delivery is the method of choice for systemic conditions: autoimmune diseases, systemic inflammation, metabolic conditions, and multi-system involvement.

Targeted Delivery Methods and Their Applications

Intrathecal (spinal): MSCs injected into the cerebrospinal fluid reach brain and spinal cord — used for neurological conditions (MS, Parkinson's, ALS, autism, stroke, SCI). Intra-articular: direct joint injection for osteoarthritis, sports injuries, and inflammatory arthropathies — concentrates MSCs at the pathological site. Intramyocardial/intracoronary: cardiac applications requiring direct myocardial delivery. Intra-tendinous: ultrasound-guided for tendinopathy. Ovarian/subendometrial: for fertility applications. Intranasal: experimental route for CNS delivery in some centres.

Why StemCell Longevita Uses Combined Delivery

For most conditions, optimal outcomes require combining systemic IV treatment with targeted delivery. Example: autism protocol — intrathecal MSCs address CNS neuroinflammation directly, while IV infusion modulates the systemic immune environment (gut-brain axis, peripheral inflammatory cytokines). Example: MS protocol — intrathecal + IV dual delivery provides both CNS-specific neuroprotection and systemic immune reset. Combined delivery is our standard approach for neurological and complex multi-system conditions.

Frequently Asked Questions

How does stem cell therapy treat osteoarthritis?

MSCs promote cartilage regeneration, reduce joint inflammation, and stimulate the body's natural repair mechanisms. This can restore joint function and provide significant pain relief without joint replacement surgery.

Can stem cells regrow cartilage?

MSCs have the ability to differentiate into chondrocytes (cartilage cells) and stimulate existing cartilage repair. While complete cartilage regeneration depends on the extent of damage, significant improvements in cartilage thickness and quality are documented.

How long do results last for osteoarthritis?

Most patients experience pain relief and improved function lasting 12-24 months or longer from a single treatment. Many patients choose annual maintenance treatments to sustain and build upon their results.

Which joints can be treated for osteoarthritis?

We treat osteoarthritis in all major joints including knees, hips, shoulders, hands, ankles, and spine. Treatment can target one or multiple joints depending on the patient's condition.

Related articles: Mesenchymal Stem Cells (MSCs): What Every Patient Should Know | Is Stem Cell Therapy Safe? Understanding Risks, Benefits & Evidence | Understanding Stem Cell Therapy (2026 Complete Guide) | Cellular Therapy Products: Types, Sources & Quality Standards (2026 Guide)

Related treatments: Osteoarthritis Stem Cell Therapy | Multiple Sclerosis Stem Cell Therapy | Chronic Pain Stem Cell Therapy